Table 1 Characteristics of the patients who did not receive surgery
Survival group (n = 20) | Mortality group (n = 6) | P value | |
|---|---|---|---|
2013–2017, n (%) | 12 (70.6) | 5 (29.4) | |
2018–2022, n (%) | 8 (88.9) | 1 (11.1) | |
Age at admission, days | 6 (0–15.5) | 9.5 (0–19.0) | 0.929 |
Weight, kg | 3.1 (2.8–3.5) | 3.5 (2.8–4.2) | 0.387 |
Male, n (%) | 13 (65.0) | 5 (83.3) | 0.393 |
Gestational age, weeks | 38 (37–39) | 38 (37–39) | 0.700 |
< 37 wk n (%) | 3 (15.0) | 0 (0.0) | |
Prenatal diagnosis of CHD, n (%) | 8 (40.0) | 2 (33.3) | 0.768 |
Preoperative location, n (%) | 0.227 | ||
Pediatric ward | 9 (45.0) | 5 (83.3) | |
NICU | 4 (20.0) | 0 (0) | |
CICU | 7 (35.0) | 1 (16.7) | |
Preoperative emergent resuscitation, n (%) | 1 (5.0) | 5 (83.3) | 0.000 |
Preoperative respiratory support, n (%) | 0.001 | ||
Noninvasive ventilation | 17 (85.0) | 1 (16.7) | |
Invasive mechanical ventilation | 3 (15.0) | 5 (83.3) | |
Diagnose, n (%) | 0.125 | ||
TGA/IVS | 11 (55.0) | 4 (66.7) | |
TGA/VSD | 2 (10.0) | 2 (33.3) | |
TAPVC | 3 (15.0) | 0 (0.0) | |
IAA | 3 (15.0) | 0 (0.0) | |
PA/IVS | 1 (5.0) | 0 (0.0) | |
Preoperative lac, mmol/L | 2.0 (1.5–2.9) | 6.5 (4.5–11.9) | 0.016 |